Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.
Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM, Stevens G, McGregor J, Jahnke K, Lacy CA, Hedrick NA, Shalom E, Ference S, Bell S, Sorenson L, Tyson RM, Haluska M, Neuwelt EA.
Angelov L, et al. Among authors: ference s.
J Clin Oncol. 2009 Jul 20;27(21):3503-9. doi: 10.1200/JCO.2008.19.3789. Epub 2009 May 18.
J Clin Oncol. 2009.
PMID: 19451444
Free PMC article.